Glatt Technology Center: Service from Feasibility Study to Production Plant

Glatt Technology Center: Service from Feasibility Study to Production Plant

Innovation - Glatt's Technology Center in Weimar stands for innovative technologies for the production of granules and pellets from powders and/or solid-containing liquids.

In the last 12 months alone, more than 120 customers from 17 countries used the company's advanced equipment to develop new product forms by feasibility studies or to optimize the properties of already established products for their production processes. Apparatuses and plants of different sizes are available for such studies - from a laboratory via a pilot up to a production scale.

Glatt Ingenieurtechnik, celebrating its 20th anniversary this year, sees itself as a full-service provider a partner for its customers from project initiation, development, implementation, commissioning up to the process engineering and technical service in a cross-sector and competent manner. Already established in 1991, the Weimar Technology Center was vastly extended and future-oriented equipped with advanced systems in 2009. After one year of successful operation under the new conditions, all expectations were exceeded.

At the heart of all process engineering activities are fluid and spouted bed technologies for the production of innovative products for all powder processing industries. The focus is on continuous processes, but also batch processes are offered. Engineers from Weimar were always one step ahead when it comes to the processing of powdery substances into attractive, dust-free, easy dosage and easily soluble granules and agglomerates for food, detergents, fertilizers, pesticides, pharmaceuticals and many other applications.

Its combination from process diversity and advanced apparatuses has long since made the Glatt competence center to be an internationally recognized hub for the above processes and the schedule for application tests is booked up months in advance.

The equipment of Glatt's Weimar Technology Center ranges from latest fluid bed and spouted bed plants up to complementary apparatuses such as high-shear granulators, extruders, pelletizers and tablet presses. A certification as per ISO 2010:9001 and an established HACCP system for the contract manufacturing unit underline Glatt's quality standards.

The laboratory, which was also upgraded, uses a great variety of devices for the determination of product properties including digital microscopy, particle size and shape distribution (laser diffraction), thermoanalysis (TGA, DSC), sorption and desorption, abrasion, bulk density, humidity as well as fluid properties such as particle size or droplet distribution in suspensions or emulsions, fluid rheology, pH value and conductance.

Moreover, the Weimar technology site is networked with many renowned scientific institutions such as universities, colleges and research institutes at home and abroad. This is the basis for ongoing improvements. Glatt Ingenieurtechnik presently owns about 100 process and apparatus patents all over the world. 

Company

Logo:

Glatt Ingenieurtechnik GmbH

Grunaer Weg 26
Dresden
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.